Oncology Business Management | Specialty

The National Comprehensive Cancer Network Conference: Clinical Practice Guidelines and Quality Cancer Care

June 11th 2010

The 13th annual conference of The National Comprehensive Cancer Network (NCCN) was held in Hollywood, Florida, from March 5-9, 2008. Attendees were provided with updates to the organization's Clinical Practice Guidelines in Oncology, protocols that, according to NCCN (a not-for-profit alliance of 21 of the world's leading cancer centers), currently cover the management of more than 97% of all cancer patients. Updated treatment guidelines were presented for an array of disease states, including breast cancer, leukemia, colon and rectal cancer, kidney cancer, multiple myeloma, and lung cancer.

Meeting Coverage for the Community-Based Oncologist

June 11th 2010

In this issue, we provide a general overview of the 13th meeting of the National Comprehensive Cancer Network (NCCN)as well as session highlights,focusing on updated treatment guidelines. Our editors attended the Sixth International Symposium on Supportive Care in Oncology,Cancer Management in the Era of Targeted Agents,and present both the hope and the challenge of these "super drugs".

Physician's Financial News: June 10, 2010

June 10th 2010

Clinical Trial Reports: June 10, 2010

June 10th 2010

Pegylated Liposomal Doxorubicin (Doxil) and Drug Combinations in Multiple Myeloma

June 10th 2010

Current treatment approaches for mutiple myeloma focus on improving progression-free and overall survival. Although five-year survival rates have increased significantly over the past ten years, the prognosis of the disease is generally poor. The availability of several promising new therapies offers clinicians treatment options to further improve response rates, especially through the development of new combination regimens.

Reimbusement and Managed Care News

June 10th 2010

Clinical Abstracts From Overseas: June 10, 2010

June 10th 2010

OncLive News Briefs: June 9, 2010

June 9th 2010

ASCO Policy Change Creates Massive Avalanche of Pre-Meeting Data

June 9th 2010

When ASCO decision-makers decided to revise the manner in which they disseminate eagerly anticipated clinical research data, the news made headlines and reverberations that were felt throughout the worlds of oncology research, practice, finance, and investment.

The American Association for Cancer Research Annual Meeting

June 9th 2010

The American Association for Cancer Research (AACR), Philadelphia, is considered the world�s oldest and largest oncology-related scientific organization. Currently celebrating its centennial, the AACR recently held its 100th annual meeting at the San Diego Convention Center from April 12�16, 2008. The following sections provide a general overview of breaking news and session highlights from the conference.

Practical Information for the Community-Based Oncologist

June 9th 2010

This issue's cover story focuses on the 100th annual meeting of the American Association of Cancer Research held April 12-16 in San Diego,providing a general overview of breaking new and session highlights.

The Academy: June 9, 2010

June 9th 2010

Academic research is fueling tremendous strides in oncology and biotechnology. The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Physicians Financial News: June 8, 2010

June 8th 2010

Pegfilgrastim for Reducing Incidence of Infection by Febrile Neutropenia

June 8th 2010

New research presented at ASCO highlights advantages of pegfilgrastim in patients receiving chemotherapy for a wide variety of solid tumors and hematologic malignancies.

The Management of Oral Mucositis in Oncology

June 8th 2010

Oral mucositis is a costly consequence of cancer therapy that can impede the efficacy of anticancer therapy. Simple preventive measures can greatly improve the patient�s outcome and quality of life.

Clinical Trial Reports: June 7, 2010

June 7th 2010

Reimbursement and Managed Care News: June 7, 2010

June 7th 2010

Clinical Abstracts From Overseas: June 7, 2010

June 7th 2010

New Angiogenesis Inhibitor May Be Effective Against a Broad Range of Cancers

June 7th 2010

Researchers at Children's Hospital Boston say that they have developed the first oral, broad-spectrum angiogenesis inhibitor that may offer a potential nontoxic therapy for a wide range of cancers. The drug was formulated through nanotechnology and has shown promising anticancer results in mice.

Managing Hypertension Associated With VEGF Inhibitors

June 3rd 2010

Patients with cancer whose treatment includes any drug that inhibits signaling via the vascular endothelial growth factor (VEGF) pathway should receive regular blood pressure (BP) monitoring according to a panel of experts convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Drug Steering Committee.